Was the flu drug zanamivir a breakthrough or money for old rope? While Relenza's benefits are modest at best, its story would make a great Hollywood blockbuster

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

2 Citations (Scopus)
Original languageEnglish
Article numberg3611
Number of pages2
JournalBritish Medical Journal
Publication statusPublished - 2 Jun 2014

Student Theses

Preventing Overdiagnosis

Author: Moynihan, R., 13 Jun 2016

Supervisor: Glasziou, P. P. (Supervisor) & Doust, J. A. (Supervisor)

Student thesis: Doctoral Thesis


Cite this